Bruker Corporation (BRKR)
USD 37.66
(-8.48%)
USD 37.66
(-8.48%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.07 Billion USD | 22.67% |
| 2022 | 843.3 Million USD | 7.84% |
| 2021 | 782 Million USD | 17.31% |
| 2020 | 666.6 Million USD | -3.1% |
| 2019 | 687.9 Million USD | 11.29% |
| 2018 | 618.1 Million USD | 6.83% |
| 2017 | 578.6 Million USD | 7.25% |
| 2016 | 539.5 Million USD | 0.3% |
| 2015 | 537.9 Million USD | -13.96% |
| 2014 | 625.2 Million USD | -0.51% |
| 2013 | 628.4 Million USD | -1.46% |
| 2012 | 637.7 Million USD | 6.84% |
| 2011 | 596.9 Million USD | 32.56% |
| 2010 | 450.3 Million USD | 76.38% |
| 2009 | 255.3 Million USD | -34.25% |
| 2008 | 388.3 Million USD | 95.61% |
| 2007 | 198.5 Million USD | 21.82% |
| 2006 | 162.94 Million USD | 41.49% |
| 2005 | 115.16 Million USD | -3.7% |
| 2004 | 119.59 Million USD | -4.73% |
| 2003 | 125.52 Million USD | 129.27% |
| 2002 | 54.75 Million USD | 19.47% |
| 2001 | 45.83 Million USD | 13.78% |
| 2000 | 40.28 Million USD | 20.67% |
| 1999 | 33.38 Million USD | -21.21% |
| 1998 | 42.36 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 277.9 Million USD | -13.35% |
| 2024 Q3 | 381.9 Million USD | 11.19% |
| 2024 Q2 | 315.4 Million USD | 13.49% |
| 2023 Q2 | 248.9 Million USD | 7.42% |
| 2023 FY | 1.03 Billion USD | 22.67% |
| 2023 Q1 | 231.7 Million USD | 1.53% |
| 2023 Q4 | 320.7 Million USD | 28.85% |
| 2023 Q3 | 248.9 Million USD | 0.0% |
| 2022 FY | 843.3 Million USD | 7.84% |
| 2022 Q1 | 202.3 Million USD | -4.3% |
| 2022 Q2 | 213.7 Million USD | 5.64% |
| 2022 Q3 | 201 Million USD | -5.94% |
| 2022 Q4 | 228.2 Million USD | 13.53% |
| 2021 FY | 782 Million USD | 17.31% |
| 2021 Q3 | 193.4 Million USD | 1.47% |
| 2021 Q2 | 190.6 Million USD | 2.14% |
| 2021 Q1 | 186.6 Million USD | -0.48% |
| 2021 Q4 | 211.4 Million USD | 9.31% |
| 2020 Q3 | 162.9 Million USD | 11.19% |
| 2020 FY | 666.6 Million USD | -3.1% |
| 2020 Q4 | 187.5 Million USD | 15.1% |
| 2020 Q2 | 146.5 Million USD | -13.67% |
| 2020 Q1 | 169.7 Million USD | -4.12% |
| 2019 FY | 687.9 Million USD | 11.29% |
| 2019 Q4 | 177 Million USD | 3.27% |
| 2019 Q1 | 166.5 Million USD | 2.71% |
| 2019 Q2 | 173 Million USD | 3.9% |
| 2019 Q3 | 171.4 Million USD | -0.92% |
| 2018 Q1 | 153.5 Million USD | -1.35% |
| 2018 Q2 | 154.2 Million USD | 0.46% |
| 2018 FY | 618.1 Million USD | 6.83% |
| 2018 Q4 | 162.1 Million USD | 9.31% |
| 2018 Q3 | 148.3 Million USD | -3.83% |
| 2017 Q1 | 135.7 Million USD | -1.88% |
| 2017 FY | 578.6 Million USD | 7.25% |
| 2017 Q3 | 143.8 Million USD | 0.21% |
| 2017 Q4 | 155.6 Million USD | 8.21% |
| 2017 Q2 | 143.5 Million USD | 5.75% |
| 2016 FY | 539.5 Million USD | 0.3% |
| 2016 Q4 | 138.3 Million USD | 2.67% |
| 2016 Q3 | 134.7 Million USD | -2.18% |
| 2016 Q2 | 137.7 Million USD | 6.91% |
| 2016 Q1 | 128.8 Million USD | -7.8% |
| 2015 Q3 | 130.4 Million USD | -4.12% |
| 2015 FY | 537.9 Million USD | -13.96% |
| 2015 Q4 | 139.7 Million USD | 7.13% |
| 2015 Q1 | 131.8 Million USD | -17.68% |
| 2015 Q2 | 136 Million USD | 3.19% |
| 2014 Q1 | 155.5 Million USD | -7.11% |
| 2014 Q3 | 150.1 Million USD | -5.89% |
| 2014 Q4 | 160.1 Million USD | 6.66% |
| 2014 FY | 625.2 Million USD | -0.51% |
| 2014 Q2 | 159.5 Million USD | 2.57% |
| 2013 FY | 628.4 Million USD | -1.46% |
| 2013 Q4 | 167.4 Million USD | 10.71% |
| 2013 Q3 | 151.2 Million USD | -1.56% |
| 2013 Q2 | 153.6 Million USD | -1.66% |
| 2013 Q1 | 156.2 Million USD | -10.64% |
| 2012 FY | 637.7 Million USD | 6.84% |
| 2012 Q1 | 156 Million USD | 1.1% |
| 2012 Q2 | 166.1 Million USD | 6.47% |
| 2012 Q3 | 150.3 Million USD | -9.51% |
| 2012 Q4 | 174.8 Million USD | 16.3% |
| 2011 FY | 596.9 Million USD | 32.56% |
| 2011 Q1 | 139.4 Million USD | -6.32% |
| 2011 Q3 | 151.9 Million USD | 4.83% |
| 2011 Q2 | 144.9 Million USD | 3.95% |
| 2011 Q4 | 154.3 Million USD | 1.58% |
| 2010 Q3 | 107.6 Million USD | 10.02% |
| 2010 Q2 | 97.8 Million USD | -1.11% |
| 2010 FY | 450.3 Million USD | 76.38% |
| 2010 Q4 | 148.8 Million USD | 38.29% |
| 2010 Q1 | 98.9 Million USD | -8.85% |
| 2009 Q1 | 88.4 Million USD | -13.43% |
| 2009 FY | 255.3 Million USD | -34.25% |
| 2009 Q4 | 108.5 Million USD | 76.14% |
| 2009 Q3 | 61.6 Million USD | -33.04% |
| 2009 Q2 | 92 Million USD | 4.07% |
| 2008 FY | 388.3 Million USD | 95.61% |
| 2008 Q4 | 102.11 Million USD | 7.56% |
| 2008 Q3 | 94.93 Million USD | -4.91% |
| 2008 Q2 | 99.84 Million USD | 9.24% |
| 2008 Q1 | 91.4 Million USD | 59.63% |
| 2007 Q1 | 44.86 Million USD | -5.22% |
| 2007 Q2 | 46 Million USD | 2.53% |
| 2007 FY | 198.5 Million USD | 21.82% |
| 2007 Q3 | 50.37 Million USD | 9.51% |
| 2007 Q4 | 57.26 Million USD | 13.67% |
| 2006 Q2 | 31.57 Million USD | 5.39% |
| 2006 Q1 | 29.96 Million USD | 2.6% |
| 2006 FY | 162.94 Million USD | 41.49% |
| 2006 Q3 | 38.23 Million USD | 21.09% |
| 2006 Q4 | 47.33 Million USD | 23.8% |
| 2005 FY | 115.16 Million USD | -3.7% |
| 2005 Q2 | 29.63 Million USD | 2.75% |
| 2005 Q1 | 28.84 Million USD | 3.41% |
| 2005 Q3 | 27.49 Million USD | -7.23% |
| 2005 Q4 | 29.2 Million USD | 6.23% |
| 2004 Q1 | 30.5 Million USD | -4.17% |
| 2004 Q3 | 31.47 Million USD | 0.49% |
| 2004 Q4 | 27.89 Million USD | -11.4% |
| 2004 Q2 | 31.32 Million USD | 2.68% |
| 2004 FY | 119.59 Million USD | -4.73% |
| 2003 Q2 | 14.85 Million USD | -6.31% |
| 2003 Q1 | 15.85 Million USD | -1.38% |
| 2003 Q4 | 31.83 Million USD | -6.21% |
| 2003 Q3 | 33.94 Million USD | 128.56% |
| 2003 FY | 125.52 Million USD | 129.27% |
| 2002 Q1 | 12.36 Million USD | 1.58% |
| 2002 FY | 54.75 Million USD | 19.47% |
| 2002 Q4 | 16.07 Million USD | 25.07% |
| 2002 Q3 | 12.85 Million USD | 7.82% |
| 2002 Q2 | 11.92 Million USD | -3.56% |
| 2001 Q1 | 10.8 Million USD | -17.5% |
| 2001 FY | 45.83 Million USD | 13.78% |
| 2001 Q4 | 12.16 Million USD | 5.19% |
| 2001 Q3 | 11.56 Million USD | 2.51% |
| 2001 Q2 | 11.28 Million USD | 4.41% |
| 2000 Q2 | 9.31 Million USD | 14.99% |
| 2000 Q1 | 8.1 Million USD | 0.0% |
| 2000 Q4 | 13.1 Million USD | 23.72% |
| 2000 Q3 | 10.58 Million USD | 13.63% |
| 2000 FY | 40.28 Million USD | 20.67% |
| 1999 FY | 33.38 Million USD | -21.21% |
| 1998 FY | 42.36 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -9490.164% |
| Cerus Corporation | 143.15 Million USD | -651.912% |
| OrthoPediatrics Corp. | 137.01 Million USD | -685.584% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -9374.63% |
| Talis Biomedical Corporation | 67.18 Million USD | -1502.119% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -4214.92% |
| Inogen, Inc. | 236.08 Million USD | -355.937% |
| Spectral AI, Inc. | 20.86 Million USD | -5059.126% |
| Nano-X Imaging Ltd. | 55.99 Million USD | -1822.246% |
| CVRx, Inc. | 76.14 Million USD | -1313.674% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -30410.239% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -8518.785% |
| Orthofix Medical Inc. | 667.42 Million USD | -61.276% |
| Venus Concept Inc. | 80.47 Million USD | -1237.542% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | -1802.506% |
| Bioventus Inc. | 409.91 Million USD | -162.589% |
| BrainsWay Ltd. | 28.01 Million USD | -3741.816% |
| Envoy Medical, Inc. | 17.89 Million USD | -5914.08% |
| electroCore, Inc. | 32.03 Million USD | -3260.495% |
| IceCure Medical Ltd | 16.87 Million USD | -6278.289% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -2436.765% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -6004.454% |
| MaxCyte, Inc. | 84.84 Million USD | -1168.666% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -8572.415% |
| Nexalin Technology, Inc. | 5.78 Million USD | -18518.469% |
| PAVmed Inc | 64.82 Million USD | -1560.419% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -2007.365% |
| RxSight, Inc. | 103.85 Million USD | -936.495% |
| Sight Sciences, Inc. | 126.44 Million USD | -751.252% |
| SI-BONE, Inc. | 156.35 Million USD | -588.451% |
| TELA Bio, Inc. | 84.18 Million USD | -1178.582% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | -1436.485% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | -429.295% |
| LivaNova PLC | 843.54 Million USD | -27.604% |
| 908 Devices Inc. | 68.08 Million USD | -1481.081% |
| Alphatec Holdings, Inc. | 483.59 Million USD | -122.582% |
| Nemaura Medical Inc. | 7.13 Million USD | -14978.158% |
| NeuroPace, Inc. | 75.29 Million USD | -1329.558% |
| LENSAR, Inc. | 33.33 Million USD | -3128.942% |
| Apyx Medical Corporation | 51.01 Million USD | -2009.844% |
| Cutera, Inc. | 197.72 Million USD | -444.395% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -4243.65% |
| BioSig Technologies, Inc. | 28.53 Million USD | -3672.871% |
| Anika Therapeutics, Inc. | 191.47 Million USD | -462.162% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -2885.025% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | -28.696% |
| Axonics, Inc. | 270.2 Million USD | -298.369% |
| Outset Medical, Inc. | 198.77 Million USD | -441.53% |
| IRIDEX Corporation | 31.81 Million USD | -3283.416% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | -497.273% |
| IRadimed Corporation | 30.12 Million USD | -3473.372% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -12516.034% |
| INVO Bioscience, Inc. | 7.85 Million USD | -13606.352% |
| Telesis Bio, Inc. | 63.48 Million USD | -1595.412% |
| Viemed Healthcare, Inc. | 98.45 Million USD | -993.314% |
| Varex Imaging Corporation | 224.8 Million USD | -378.826% |
| Quipt Home Medical Corp. | 148.66 Million USD | -624.034% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -9081.95% |
| Pulmonx Corporation | 112.68 Million USD | -855.212% |
| Dynatronics Corporation | 9.9 Million USD | -10763.92% |
| Modular Medical, Inc. | 17.52 Million USD | -6040.681% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -5232.144% |
| Semler Scientific, Inc. | 38.94 Million USD | -2663.969% |
| InMode Ltd. | 215.68 Million USD | -399.073% |
| Cytosorbents Corporation | 48.33 Million USD | -2126.872% |
| DexCom, Inc. | 1.69 Billion USD | 36.353% |
| Align Technology, Inc. | 2.07 Billion USD | 48.171% |
| Viveve Medical, Inc. | 22.17 Million USD | -4754.553% |
| ZimVie Inc. | 275.12 Million USD | -291.239% |
| Movano Inc. | 29.69 Million USD | -3525.463% |
| Cytek Biosciences, Inc. | 137.27 Million USD | -684.142% |
| Nexalin Technology, Inc. | 5.78 Million USD | -18518.469% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -30410.239% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | -79.125% |
| Profound Medical Corp. | 33.6 Million USD | -3103.272% |
| Insulet Corporation | 939.9 Million USD | -14.523% |
| enVVeno Medical Corporation | 25.23 Million USD | -4164.997% |
| Surmodics, Inc. | 98.69 Million USD | -990.611% |
| iCAD, Inc. | 22.22 Million USD | -4743.195% |
| Nuwellis, Inc. | 22.61 Million USD | -4660.094% |
| Biotricity, Inc. | 17.18 Million USD | -6163.766% |
| iRhythm Technologies, Inc. | 445.88 Million USD | -141.405% |
| Aethlon Medical, Inc. | 12.27 Million USD | -8667.249% |
| InspireMD, Inc. | 22.95 Million USD | -4590.196% |
| PAVmed Inc. | 64.82 Million USD | -1560.419% |
| BIOLASE, Inc. | 34.66 Million USD | -3005.508% |
| Beyond Air, Inc. | 61.7 Million USD | -1644.571% |
| FONAR Corporation | 28.6 Million USD | -3663.02% |
| AxoGen, Inc. | 149.33 Million USD | -620.791% |
| Vivani Medical, Inc. | 26.96 Million USD | -3891.841% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | -507.82% |
| Inari Medical, Inc. | 448.59 Million USD | -139.949% |
| UFP Technologies, Inc. | 58.08 Million USD | -1753.019% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -21744.31% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -16936.258% |
| Tenon Medical, Inc. | 16.96 Million USD | -6243.706% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -14459.719% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -2340.659% |
| AdaptHealth Corp. | 1.07 Billion USD | 0.145% |
| Sintx Technologies, Inc. | 15.2 Million USD | -6981.113% |
| NanoVibronix, Inc. | 4.97 Million USD | -21544.882% |
| Quanterix Corporation | 118.1 Million USD | -811.431% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -9081.95% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -7353.261% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | -174.126% |
| TransMedics Group, Inc. | 182.82 Million USD | -488.776% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -3735.382% |
| NeuroMetrix, Inc. | 11.09 Million USD | -9598.229% |
| Hyperfine, Inc. | 52.87 Million USD | -1935.86% |
| Establishment Labs Holdings Inc. | 172 Million USD | -525.803% |
| Biomerica, Inc. | 6.97 Million USD | -15325.623% |
| Bone Biologics Corporation | 9.42 Million USD | -11316.689% |
| AVITA Medical, Inc. | 80.77 Million USD | -1232.521% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -10339.118% |
| Silk Road Medical, Inc | 186.35 Million USD | -477.601% |